SCHEMBL14374178

SCHEMBL14374178

CCc1nc(=O)[nH]c2c1ccc1ncccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ ACVR1 Q04771 4/20 0.41
▸ CYP19A1 P11511 3/20 0.41
▸ NCOA1 Q15788 1/20 0.39
▸ PDE3B Q13370 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ TNKS2 Q9H2K2 1/20 0.37
▸ KDM4D Q6B0I6 1/20 0.37
▸ BMPR1B O00238 1/20 0.36
▸ RAF1 P04049 1/20 0.36
▸ BRAF P15056 1/20 0.36
▸ BMPR1A P36894 1/20 0.36
▸ ACVR1B P36896 1/20 0.36
▸ TGFBR1 P36897 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14374170 0.81 MAPT (0.56) KDM4EMAPTPDE3BPDE3ACYP3A4
SCHEMBL14347279 0.80 MAPT (0.42) KDM4EMAPTACVR1CYP19A1NCOA1
SCHEMBL14374978 0.74 TSHR (0.51) KDM4EMAPTSMN1; SMN2LMNA
SCHEMBL14374785 0.73 CYP1A2 (0.53) KDM4EMAPTACVR1NCOA1CYP3A4
SCHEMBL1982985 0.73 CYP3A4 (0.47) KDM4EMAPTACVR1NCOA1CYP3A4
SCHEMBL14374778 0.73 RXFP1 (0.43) KDM4E
SCHEMBL14374177 0.72 DYRK1A (0.38) PDE3BPDE3A
SCHEMBL14374782 0.72 PDE10A (0.41) KDM4EMAPTACVR1CYP19A1NCOA1
SCHEMBL6191956 0.70 KDM4E (0.53) KDM4EPDE3BPDE3ACYP1A2SMN1; SMN2
SCHEMBL14374834 0.70 SMN1; SMN2 (0.49) KDM4ESMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312211-B2 Pryanone compounds useful as reversible inhibitors of cysteine proteases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2007-12-25 — — US disclosed
Send feedback